Skip to main content
. 2020 Mar 2;2020(3):CD005004. doi: 10.1002/14651858.CD005004.pub3

Shannon 2010.

Study name Fish oil and green tea extract in preventing prostate cancer in patients who are at risk for developing prostate cancer
ClinicalTrial ID: Shannon 2010
Methods Randomised, double‐blind, placebo‐controlled study
Participants Men at high risk of prostate cancer
Participants are stratified according to age (< 65 vs ≥ 65)
Interventions Intervention group A: GTE polyphenols (75%) and EGCG (at least 30% = 300 mg) per 1000 mg capsule (2 capsules/d)
Intervention group B: fish oil capsule per 1000 mg with ethyl esters of eicosapentaenoic acid (20:5n‐3) and docosahexanoic acid (3 capsules/d)
Intervention group C: A+B
Control group: placebo, olive oil capsule 2/3 times/d
Duration: 12 weeks
Outcomes Primary outcomes
Fatty acid synthase expression by immunohistochemistry at pre‐ and post‐intervention (FAS Summary Score)
Cell proliferation by Ki67‐immunohistochemistry at pre‐ and post‐intervention
Incidence of prostate cancer
Starting date July 2005
Contact information Jackie Shannon, Principal Investigator, OHSU Knight Cancer Institute
Notes According to 2010 abstract 67 men completed the study, 4 were enrolled. Anticipated sample size 120 men, or 30 men/group

EGCG: epigallocatechin‐3‐gallate; ESCC: (o)esophageal squamous cell carcinoma; FAS: fatty acid synthase; GTE: green tea extract; RCT: randomised controlled trial